PL437793A1 - Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum) - Google Patents

Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum)

Info

Publication number
PL437793A1
PL437793A1 PL437793A PL43779321A PL437793A1 PL 437793 A1 PL437793 A1 PL 437793A1 PL 437793 A PL437793 A PL 437793A PL 43779321 A PL43779321 A PL 43779321A PL 437793 A1 PL437793 A1 PL 437793A1
Authority
PL
Poland
Prior art keywords
application
bovine colostrum
butter obtained
ghee
ghee butter
Prior art date
Application number
PL437793A
Other languages
English (en)
Inventor
Michał Łusiak
Jakub FICHNA
Maciej Sałaga
Marcin Talar
Paula Mosińska
Aleksandra Tarasiuk
Julia Krajewska
Adam Fabisiak
Agata Binienda
Adrian Bartoszek
Katarzyna Dziedziczak
Karolina Niewinna
Original Assignee
Uniwersytet Medyczny w Łodzi
Łusiak Michał Przedsiębiorstwo Wielobranżowe Proszki Mleczne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny w Łodzi, Łusiak Michał Przedsiębiorstwo Wielobranżowe Proszki Mleczne filed Critical Uniwersytet Medyczny w Łodzi
Priority to PL437793A priority Critical patent/PL437793A1/pl
Priority to CZ2022-188A priority patent/CZ309662B6/cs
Publication of PL437793A1 publication Critical patent/PL437793A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Przedmiotem wynalazku jest masło Ghee otrzymywane z siary bydlęcej (colostrum) do zastosowania w profilaktyce i leczeniu chorób jelit.
PL437793A 2021-05-07 2021-05-07 Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum) PL437793A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL437793A PL437793A1 (pl) 2021-05-07 2021-05-07 Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum)
CZ2022-188A CZ309662B6 (cs) 2021-05-07 2022-05-06 Použití ghí másla získaného z kravského mleziva, kolostra

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL437793A PL437793A1 (pl) 2021-05-07 2021-05-07 Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum)

Publications (1)

Publication Number Publication Date
PL437793A1 true PL437793A1 (pl) 2022-11-14

Family

ID=83997714

Family Applications (1)

Application Number Title Priority Date Filing Date
PL437793A PL437793A1 (pl) 2021-05-07 2021-05-07 Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum)

Country Status (2)

Country Link
CZ (1) CZ309662B6 (pl)
PL (1) PL437793A1 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
CA3013835A1 (en) * 2016-02-16 2017-08-24 Atp Institute Pty Ltd Formulation and method of use
CN109619140A (zh) * 2019-02-02 2019-04-16 祁连播森农牧科技开发有限公司 一种含有酥油的有机营养曲奇饼干及其制备方法

Also Published As

Publication number Publication date
CZ309662B6 (cs) 2023-06-21
CZ2022188A3 (cs) 2022-11-16

Similar Documents

Publication Publication Date Title
CO2021000326A2 (es) Composiciones y métodos para aumentar o mejorar la transducción de vectores de terapia genética y para eliminar o reducir las inmunoglobulinas
BR112022015416A2 (pt) Anticorpos anti-ror1 e composições
MX2023009681A (es) Composiciones de anticuerpos anti-tl1a y metodos de tratamiento en el pulmon.
MX2024005705A (es) Composiciones de liquidos ionicos.
EP4667572A3 (en) THERAPEUTIC TREATMENT OF UNSTABLE MICROSATELLITE CANCERS
CY1125104T1 (el) Συνθεσεις φλαγελλινης entrecoccus για χρηση στη θεραπεια
CO2022010592A2 (es) Métodos de tratamiento de la esplenomegalia
EA202190310A1 (ru) Белок для лечения воспалительных заболеваний
WO2021191689A3 (en) Treatment of inflammatory diseases with peptides and pharmaceutical compositions
EP4255385A4 (en) ANTIGEN COMPOSITION(S) AND METHOD(S) AGAINST PORPHYROMONAS GINGIVALIS FOR THE PREVENTION AND/OR TREATMENT OF INFECTIONS AND/OR DISEASES
MX2025000151A (es) Agonistas de trpml1 con oxazol y usos de los mismos
EA202191686A1 (ru) Гидролизат коллагена для применения против кожных болезней и кишечных заболеваний
PH12021552135A1 (en) Methods of treating al amyloidosis
CL2022000294A1 (es) Composiciones biofarmacéuticas y procedimientos conexos.
EP4112716A4 (en) Lactobacillus helveticus strain and composition containing same for prevention or treatment of inflammatory diseases
MX2023010661A (es) Moléculas de union al receptor leucocitario humano similar a inmunoglobulina b1 (lilrb1) y al receptor leucocitario humano similar a inmunoglobulina b2 (lilrb2) y usos para las mismas.
EP3804759A4 (en) METHODS OF TREATMENT OF DANDRUFF OR PREVENTION OF GNASE 1 SECONDARY DISEASES
MX2022013770A (es) Relaxinas modificadas y metodos de uso de las mismas.
EP4099997A4 (en) METHODS AND COMPOSITIONS FOR TREATING DISEASES
EP4433045A4 (en) Formulations and methods for treating menopausal symptoms
EP4380580A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF MISFOLDING PROTEINS
Košec et al. Hypertrophic recurring lichen planus of the external auditory canal
BR112022020342A2 (pt) Inibidores da quinase
MX2025001060A (es) Degradación de proteínas dirigida de parp14 para usar en terapia.
CL2024002103A1 (es) Métodos para tratar amiloidosis al